Product Description
Pneumococcal Conjugate Vaccines
Mechanisms of Action: Vaccine
Novel Mechanism: No
Modality: Vaccine
Route of Administration: Intramuscular
FDA Designation: *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: University of Witwatersrand, South Africa
Company Location:
Company Founding Year: None
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Phase 4: Pneumonia, Pneumococcal|Malnutrition|Pneumococcal Infections|Communicable Diseases
Phase 3: Otitis Media|Sepsis|Pneumonia|Meningitis|Bacteremia|Nasopharyngeal Diseases|Maternal Death|Meningitis, Pneumococcal|Acute Respiratory Distress Syndrome|Measles|Influenza, Human|Meningitis, Haemophilus|Vision, Low|Pneumonia, Pneumococcal|Sneezing
Phase 2: Pregnancy Outcomes|HIV Infections
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|---|---|---|---|---|---|---|---|
NCT04275284 |
PCV1+1_FU | N/A |
Completed |
Pneumonia|Meningitis |
2022-12-01 |
2024-05-29 |
Primary Endpoints|Treatments|Trial Status |
|
NCT03064620 |
PICRcarriage | N/A |
Unknown status |
Pneumonia, Pneumococcal |
2020-08-01 |
2022-01-04 |
Primary Endpoints |
|
NCT04912297 |
THL/1019/6.00.00/2017 | N/A |
Completed |
Pneumonia, Pneumococcal|Pneumococcal Infections |
2013-05-07 |
2021-06-04 |
Primary Endpoints |
|
ACTRN12611000383965 |
OMIVI (Otitis Media Infectious aetiology & Vaccination Impact) | N/A |
Not yet recruiting |
Otitis Media |
None |
2024-04-03 |
Treatments |
|
NCT02717494 |
NICHD P1091 | P2 |
Completed |
Pregnancy Outcomes|HIV Infections |
2018-11-01 |
2020-01-28 |
||
NCT02943902 |
PCV1+1 | P3 |
Completed |
Pneumonia|Meningitis |
2019-02-26 |
2019-12-10 |
Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
NCT01953510 |
10PN-PD-DIT-079 | P3 |
Completed |
Nasopharyngeal Diseases|Meningitis, Haemophilus|Maternal Death|Acute Respiratory Distress Syndrome|Meningitis, Pneumococcal|Measles|Pneumonia, Pneumococcal|Influenza, Human|Sneezing|Vision, Low |
2016-01-27 |
47% |
2022-09-15 |
Primary Endpoints|Study Completion Date |
NCT01619462 |
PCV1103 | P3 |
Unknown status |
Pneumonia|Otitis Media|Meningitis|Bacteremia|Sepsis |
2014-04-01 |
2019-03-19 |
||
NCT05175014 |
fPCV | P4 |
Completed |
Pneumonia, Pneumococcal|Malnutrition |
2023-03-14 |
2024-12-06 |
Patient Enrollment|Primary Completion Date|Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
NCT03489018 |
FPCV | P4 |
Completed |
Communicable Diseases|Pneumonia, Pneumococcal|Pneumococcal Infections |
2022-09-30 |
2024-11-13 |
Primary Endpoints|Study Completion Date|Treatments|Trial Status |
|
NCT01028326 |
PRISM | P4 |
Unknown status |
Pneumonia, Pneumococcal |
2010-09-01 |
2019-07-04 |
Treatments|Trial Status |